Anti-LT reactive antibodies have also been shown to modulate the severity of ETEC associated illness following experimental infection (McKenzie et al., 2007; Gutiérrez et al., 2024) and to protect against ETEC strains producing only LT in field studies (Clemens et al., 1988; Behrens et al., 2014). Here, LTA is linked to infection.